(Q40394789)

English

Outer membrane vesicles harboring modified lipid A moiety augment the efficacy of an influenza vaccine exhibiting reduced endotoxicity in a mouse model

scientific article published on 23 December 2016

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Outer membrane vesicles harboring modified lipid A moiety augment the efficacy of an influenza vaccine exhibiting reduced endotoxicity in a mouse model (English)

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

influenza vaccine

1 reference

based on heuristic

inferred from title

author name string

Tae-Young Lee

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28024958%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Chang-Ung Kim

2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28024958%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Eun-Hye Bae

3

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28024958%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Sang-Hwan Seo

4

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28024958%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Dae Gwin Jeong

5

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28024958%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Sun-Woo Yoon

6

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28024958%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Kyu-Tae Chang

7

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28024958%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Young Sang Kim

8

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28024958%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Sang-Hyun Kim

9

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28024958%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Doo-Jin Kim

10

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28024958%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

language of work or name

0 references

publication date

23 December 2016

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28024958%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

35

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28024958%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

4

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28024958%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

586-595

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28024958%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Role of adjuvants in modeling the immune response

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.025

7 January 2021

MF59 adjuvant: the best insurance against influenza strain diversity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.025

7 January 2021

Function of mucosa-associated lymphoid tissue in antibody formation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.025

7 January 2021

Mucosal vaccines: the promise and the challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.025

7 January 2021

Live attenuated influenza vaccine (FluMist®; Fluenz™): a review of its use in the prevention of seasonal influenza in children and adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.025

7 January 2021

Intranasal immunization of mice with a mixture of the pneumococcal proteins PsaA and PspA is highly protective against nasopharyngeal carriage of Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.025

7 January 2021

A protective and safe intranasal RSV vaccine based on a recombinant prefusion-like form of the F protein bound to bacterium-like particles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.025

7 January 2021

Bacterial outer membrane vesicles and the host-pathogen interaction

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.025

7 January 2021

Immune modulation by bacterial outer membrane vesicles.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.025

7 January 2021

Immunization with Escherichia coli outer membrane vesicles protects bacteria-induced lethality via Th1 and Th17 cell responses.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.025

7 January 2021

Assessment of mOMV adjuvant efficacy in the pathogenic H1N1 influenza virus vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.025

7 January 2021

Structural modifications of outer membrane vesicles to refine them as vaccine delivery vehicles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.025

7 January 2021

Adjuvant effect of bacterial outer membrane vesicles with penta-acylated lipopolysaccharide on antigen-specific T cell priming

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.025

7 January 2021

Lipid A modifications characteristic of Salmonella typhimurium are induced by NH4VO3 in Escherichia coli K12. Detection of 4-amino-4-deoxy-L-arabinose, phosphoethanolamine and palmitate

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.025

7 January 2021

Virulence, inflammatory potential, and adaptive immunity induced by Shigella flexneri msbB mutants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.025

7 January 2021

Molecular basis of reduced potency of underacylated endotoxins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.025

7 January 2021

Novel modification of lipid A of Francisella tularensis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.025

7 January 2021

Expression cloning and periplasmic orientation of the Francisella novicida lipid A 4'-phosphatase LpxF.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.025

7 January 2021

Escape of a plant virus from amplicon-mediated RNA silencing is associated with biotic or abiotic stress

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.025

7 January 2021

Mucosal IgA responses in influenza virus infections; thoughts for vaccine design

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.025

7 January 2021

Lung CD103+ dendritic cells efficiently transport influenza virus to the lymph node and load viral antigen onto MHC class I for presentation to CD8 T cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.025

7 January 2021

Resident CD8(+) and migratory CD103(+) dendritic cells control CD8 T cell immunity during acute influenza infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.025

7 January 2021

FimH, a TLR4 ligand, induces innate antiviral responses in the lung leading to protection against lethal influenza infection in mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.025

7 January 2021

The TLR4-TRIF pathway protects against H5N1 influenza virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.025

7 January 2021

Toll-like receptor pre-stimulation protects mice against lethal infection with highly pathogenic influenza viruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.025

7 January 2021

Intranasal Administration of the TLR2 Agonist Pam2Cys Provides Rapid Protection against Influenza in Mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.025

7 January 2021

Hemagglutinin-neuraminidase balance confers respiratory-droplet transmissibility of the pandemic H1N1 influenza virus in ferrets

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.025

7 January 2021

Changes to the dynamic nature of hemagglutinin and the emergence of the 2009 pandemic H1N1 influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.025

7 January 2021

Potential of Nasopharynx-associated Lymphoid Tissue for Vaccine Responses in the Airways

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.025

7 January 2021

Nasal vaccine innovation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.025

7 January 2021

Lipopolysaccharide endotoxins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.025

7 January 2021

The lipid A palmitoyltransferase PagP: molecular mechanisms and role in bacterial pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.025

7 January 2021

Enhancement of antigen-specific immunity via the TLR4 ligands MPL adjuvant and Ribi.529.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.025

7 January 2021

Clearance of influenza virus from the lung depends on migratory langerin+CD11b- but not plasmacytoid dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.025

7 January 2021

Complement mediated signaling on pulmonary CD103(+) dendritic cells is critical for their migratory function in response to influenza infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.025

7 January 2021

Development of a universal CTL-based vaccine for influenza.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.025

7 January 2021

Heat shock protein gp96 adjuvant induces T cell responses and cross-protection to a split influenza vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.025

7 January 2021

Development of cross-protective influenza a vaccines based on cellular responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.025

7 January 2021

Novel G3/DT adjuvant promotes the induction of protective T cells responses after vaccination with a seasonal trivalent inactivated split-virion influenza vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.025

7 January 2021

Antibody recognition of a highly conserved influenza virus epitope

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.025

7 January 2021

Broadly neutralizing influenza hemagglutinin stem-specific antibody CR8020 targets residues that are prone to escape due to host selection pressure

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.025

7 January 2021

A nontoxic mutant of cholera toxin elicits Th2-type responses for enhanced mucosal immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.025

7 January 2021

Helper T cell subsets for immunoglobulin A responses: oral immunization with tetanus toxoid and cholera toxin as adjuvant selectively induces Th2 cells in mucosa associated tissues

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.025

7 January 2021

Tryptophan catabolism and regulation of adaptive immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.025

7 January 2021

Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.025

7 January 2021

Indoleamine 2,3-dioxygenase in lung dendritic cells promotes Th2 responses and allergic inflammation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.025

7 January 2021

Mucosal adjuvant effect of cholera toxin in mice results from induction of T helper 2 (Th2) cells and IL-4

1 reference

https://pubmed.ncbi.nlm.nih.gov/28024958

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.VACCINE.2016.12.025

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28024958%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28024958%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28024958%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40394789&oldid=1896881549"